아토피피부염 환아에서 혈청 페리오스틴과 편평상피암항원
Serum periostin levels and squamous cell carcinoma-related antigen levels in children with atopic dermatitis
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: It was found that periostin and squamous cell carcinoma-related antigens (SCCAs) were strongly interleukin-13-inducible gene products. This study measures the serum periostin and SCCA levels in children suffering from atopic dermatitis (AD) and to evaluate the association between the severity of AD and their values. Methods: Seventy AD children aged 1 month to 10 years were included in our study. Subjects were characterized as having atopic eczema (AE; n=55) or non-AE (NAE; n=15) by atopic sensitization. Serum SCCA and periostin levels were measured. Results: The serum periostin levels were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 80.47 ng/mL [75.06–85.93 ng/mL] vs. 67.45 ng/mL [59.99–75.64] ng/mL, P=0.020). The serum concentrations of both SCCA1 and SCCA2 were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 1.401 [1.198–1.643] ng/mL vs. 0.969 [0.723–1.268] ng/mL, P=0.039 for SCCA1) (1.178 [0.974–1.455] ng/mL vs. 0.711 [0.540– 0.994] ng/mL, P=0.025 for SCCA2). The serum periostin levels were significantly correlated with disease severity and with peripheral blood eosinophil counts. The SCCA levels were not significantly correlated with disease severity. Both SCCA1 and SCCA2 were significantly correlated with serum periostin levels and blood eosinophil counts. Conclusion: Serum periostin levels may be significantly correlated with disease severity and blood eosinophil counts in children with AD. Serum SCCA levels can be significantly correlated with serum periostin levels and blood eosinophil counts in children with AD.
Abstract
Purpose: It was found that periostin and squamous cell carcinoma-related antigens (SCCAs) were strongly interleukin-13-inducible gene products. This study measures the serum periostin and SCCA levels in children suffering from atopic dermatitis (AD) and to evaluate the association between the severity of AD and their values. Methods: Seventy AD children aged 1 month to 10 years were included in our study. Subjects were characterized as having atopic eczema (AE; n=55) or non-AE (NAE; n=15) by atopic sensitization. Serum SCCA and periostin levels were measured. Results: The serum periostin levels were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 80.47 ng/mL [75.06–85.93 ng/mL] vs. 67.45 ng/mL [59.99–75.64] ng/mL, P=0.020). The serum concentrations of both SCCA1 and SCCA2 were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 1.401 [1.198–1.643] ng/mL vs. 0.969 [0.723–1.268] ng/mL, P=0.039 for SCCA1) (1.178 [0.974–1.455] ng/mL vs. 0.711 [0.540– 0.994] ng/mL, P=0.025 for SCCA2). The serum periostin levels were significantly correlated with disease severity and with peripheral blood eosinophil counts. The SCCA levels were not significantly correlated with disease severity. Both SCCA1 and SCCA2 were significantly correlated with serum periostin levels and blood eosinophil counts. Conclusion: Serum periostin levels may be significantly correlated with disease severity and blood eosinophil counts in children with AD. Serum SCCA levels can be significantly correlated with serum periostin levels and blood eosinophil counts in children with AD.
참고문헌 (22)
- Asher MI, "Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys", Lancet, 368, pp.733~743 (2006)
- Hamid Q, "Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis", J Clin Invest, 94, pp.870~876 (1994)
- Hamid Q, "In vivo expression of IL-12 and IL-13 in atopic dermatitis", J Allergy Clin Immunol, 98, pp.225~231 (1996)
- Novak N, "Allergic and nonallergic forms of atopic diseases", J Allergy Clin Immunol, 112, pp.252~262 (2003)
- Leung DY, "New insights into atopic dermatitis", J Clin Invest, 113, pp.651~657 (2004)
- Grewe M, "A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis", Immunol Today, 19, pp.359~361 (1998)
- Kii I, "Periostin is an extracellular matrix protein required for eruption of incisors in mice", Biochem Biophys Res Commun, 342, pp.766~772 (2006)
- Kikuchi Y, "Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon", J Histochem Cytochem, 56, pp.753~764 (2008)
- Masuoka M, "Periostin promotes chronic allergic inflammation in response to Th2 cytokines", J Clin Invest, 122, pp.2590~2600 (2012)
- Kato H, "Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma", Cancer, 40, pp.1621~1628 (1977)
- Yuyama N, "Analysis of novel disease-related genes in bronchial asthma", Cytokine, 19, pp.287~296 (2002)
- Nishi N, "Squamous cell carcinoma-related antigen in children with acute asthma", Ann Allergy Asthma Immunol, 94, pp.391~397 (2005)
- Mitsuishi K, "The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis", Clin Exp Allergy, 35, pp.1327~1333 (2005)
- Suzuki K, "Relationship between squamous cell carcinoma antigen and the clinical severity of allergic rhinitis caused by Dermatophagoides farinae and Japanese cedar pollen", Ann Otol Rhinol Laryngol, 119, pp.22~26 (2010)
- Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Derm Venereol Suppl (Stockh), 92, pp.44~47 (1980)
- "Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis", Dermatology, 186, pp.23~31 (1993)
- Okamoto M, "Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias", Eur Respir J, 37, pp.1119~1127 (2011)
- Furue M, "Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis", J Invest Dermatol, 96, pp.468~472 (1991)
- Niebuhr M, "Innate immunity, allergy and atopic dermatitis", Curr Opin Allergy Clin Immunol, 10, pp.463~468 (2010)
- Kou K, "Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis", Br J Dermatol, 171, pp.283~291 (2014)
- Izuhara K, "IL-13: a promising therapeutic target for bronchial asthma", Curr Med Chem, 13, pp.2291~2298 (2006)
- Ohta S, "The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis", Ann Clin Biochem, 49(Pt 3), pp.277~284 (2012)